BioLife Solutions, Inc. Total Liabilities and Equity
BioLife Solutions, Inc. (BLFS) had Total Liabilities and Equity of $447.49 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet
us-gaap:LiabilitiesAndStockholdersEquity · last filed 2026-08-06
- 2026-06-30: Liabilities and Equity $447.49M.
- 2026-03-31: Liabilities and Equity $400.91M.
- 2025-12-31: Liabilities and Equity $405.88M.
- 2025-09-30: Liabilities and Equity $392.08M.
| Period end | Liabilities and Equity | Liabilities and Equity as first filed |
|---|---|---|
| 2026-06-30 | $447.49M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $400.91M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $405.88M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $392.08M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $387.24M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $395.14M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $399.49M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $381.65M 10-Q · filed 2024-11-12 | |
| 2024-06-30 | $374.98M 10-Q · filed 2024-08-09 | |
| 2024-03-31 | $401.60M 10-Q · filed 2024-05-10 | |
| 2023-12-31 | $412.71M 10-K · filed 2025-03-03 | |
| 2023-09-30 | $411.15M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | $433.18M 10-Q · filed 2023-08-09 | |
| 2023-03-31 | $446.47M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | $450.23M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $488.02M 10-Q · filed 2023-11-09 | $487.68M 10-Q · filed 2022-11-09 |
| 2022-06-30 | $470.68M 10-Q · filed 2023-08-09 | $470.38M 10-Q · filed 2022-08-09 |
| 2022-03-31 | $544.28M 10-Q · filed 2023-05-11 | $544.01M 10-Q · filed 2022-05-10 |
| 2021-12-31 | $554.29M 10-K · filed 2023-03-31 | $554.06M 10-K · filed 2022-03-31 |
| 2021-09-30 | $559.39M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $520.97M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $240.02M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $234.83M 10-K · filed 2022-03-31 | |
| 2020-09-30 | $195.89M 10-Q · filed 2020-11-09 | |
| 2020-06-30 | $113.97M 10-Q · filed 2020-08-10 | |
| 2020-03-31 | $94.99M 10-Q · filed 2020-05-29 | |
| 2019-12-31 | $92.82M 10-K · filed 2021-03-31 | |
| 2019-09-30 | $83.79M 10-K · filed 2020-05-15 | $84.23M 10-Q · filed 2019-11-12 |
| 2019-06-30 | $51.30M 10-K · filed 2020-05-15 | $51.74M 10-Q · filed 2019-08-09 |
| 2019-03-31 | $48.07M 10-K · filed 2020-05-15 | |
| 2018-12-31 | $45.47M 10-K · filed 2020-05-15 | |
| 2018-09-30 | $46.45M 10-K · filed 2020-05-15 | $46.45M 10-Q · filed 2018-11-08 |
| 2018-06-30 | $21.79M 10-K · filed 2020-05-15 | $21.79M 10-Q · filed 2018-08-09 |
| 2018-03-31 | $12.29M 10-K · filed 2020-05-15 | $12.29M 10-Q · filed 2018-05-11 |
| 2017-12-31 | $12.14M 10-K · filed 2019-03-15 | $12.14M 10-K · filed 2018-03-09 |
| 2017-09-30 | $8.88M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $8.48M 10-Q · filed 2017-08-11 | |
| 2017-03-31 | $8.60M 10-Q · filed 2017-05-12 | |
| 2016-12-31 | $7.93M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $10.77M 10-Q · filed 2016-11-10 | |
| 2016-06-30 | $10.55M 10-Q · filed 2016-08-11 | |
| 2016-03-31 | $10.78M 10-Q · filed 2016-05-16 | |
| 2015-12-31 | $12.37M 10-K · filed 2017-03-15 | |
| 2015-09-30 | $13.23M 10-Q · filed 2015-11-16 | |
| 2015-06-30 | $13.87M 10-Q · filed 2015-08-06 | |
| 2015-03-31 | $15.16M 10-Q · filed 2015-05-07 | |
| 2014-12-31 | $16.07M 10-K · filed 2016-02-25 | |
| 2014-09-30 | $14.25M 10-Q · filed 2014-11-06 | |
| 2014-06-30 | $14.81M 10-Q · filed 2014-08-07 | |
| 2014-03-31 | $15.98M 10-Q · filed 2014-05-08 | |
| 2013-12-31 | $3.35M 10-K · filed 2015-03-12 | |
| 2013-09-30 | $3.21M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $3.44M 10-Q · filed 2013-08-12 | |
| 2013-03-31 | $3.42M 10-Q · filed 2013-05-14 | |
| 2012-12-31 | $3.17M 10-K · filed 2014-02-12 | |
| 2012-09-30 | $3.42M 10-Q · filed 2012-11-13 | |
| 2012-06-30 | $3.07M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.87M 10-Q · filed 2012-05-14 | |
| 2011-12-31 | $1.66M 10-K · filed 2013-03-29 | |
| 2011-09-30 | $1.56M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $1.47M 10-Q · filed 2011-08-12 | |
| 2010-12-31 | $1.31M 10-K · filed 2012-03-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Axogen, Inc. (AXGN) | United States | $2.329B | -73.83 |
| CONMED Corp (CNMD) | United States | $1.353B | 26.72 |
| Ceribell, Inc. (CBLL) | United States | $0.916B | -11.27 |
| TransMedics Group, Inc. (TMDX) | United States | $2.911B | 15.17 |
| CapsoVision, Inc (CV) | United States | $0.310B | -12.68 |
| Electromed, Inc. (ELMD) | United States | $0.233B | 31.13 |
| EDAP TMS SA (FOCL) | $0.171B | ||
| Stereotaxis, Inc. (STXS) | United States | $0.130B | -7.53 |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| electroCore, Inc. (ECOR) | United States | $0.102B |